|
|||||
       |
(National Institutes of Health) 23 May 2014. The U.S. Food and Drug Administration approved a molecular diagnostic test to help determine genetic compatibility for blood transfusions, a particular need for people requiring frequent transfusions. The PreciseType HEA Molecular BeadChip Test is made by BioArray Solutions, a subsidiary of Immucor, a developer of diagnostics . . . → Read More: Genetic Blood Transfusion Diagnostic Approved by FDA  One comment - (Comments are closed)  Regulations  biomedical, FDA, genomics, life sciences, medical device (44444 U.A.E./Flickr) 22 May 2014. Computer scientists and medical researchers at Duke University in North Carolina developed software that uses computer vision to analyze video of an infant’s behavior for signs of autism spectrum disorder. The team from the lab of Duke computer engineering professor Guillermo Sapiro — with colleagues from Duke, University of . . . → Read More: Diagnostic Software Developed to Analyze Video for Autism Comments are closed New products biomedical, computer science, engineering, life sciences, mathematics, medical device, physical sciences, psychiatric, software, university Brown adipose tissue (Lucasmcorso/WikimediaCommons) 22 May 2014. BioRestorative Therapies Inc. in Jupiter, Florida and the pharmaceutical company Pfizer Inc. in New York are conducting a joint study of human brown fat tissue and cell lines, to discover more about their use as a platform for therapies for type 2 diabetes and obesity. Financial . . . → Read More: Pfizer, Biotech to Partner on Brown Fat Cell Research Comments are closed Joint ventures/collaborations biomedical, biotechnology, life sciences, pharmaceuticals, preclinical, stem cells, university Gemma Reguera (Michael Steger, Michigan State Univ.) 21 May 2014. Microbiologists at Michigan State University in East Lansing created a process with two types of genetically-engineered bacteria that work together to clean up the waste water in the production of biodiesel, and generate ethanol as a byproduct. The team led by Michigan State’s . . . → Read More: Engineered Microbes Created to Clean Biodiesel Waste Comments are closed New products biofuels, biotechnology, chemistry, energy, engineering, genomics, life sciences, patent, physical sciences, university Light-Line catheter (Veritas Medical LLC) 21 May 2014. Five medical and engineering students at University of Utah in Salt Lake City invented a new type of catheter that emits high-intensity light killing bacteria before they cause an infection in the patient. The students also formed a new company, Veritas Medical LLC in Salt Lake . . . → Read More: Students Invent Germ-Killing Catheter, Start Company Comments are closed New products biomedical, engineering, entrepreneurs, life sciences, medical device, patent, university (NIH.gov) 20 May 2014. Techniques for regrowing new spinal disc cartilage tissue in the body from a person’s own skin cells received a patent from the U.S. Patent and Trademark Office. Patent number 8,728,495 was awarded today to inventors Lionel Sevrain and Sylvie Sevrain-Verdier and assigned to SpinalCyte LLC in Houston. Sevrain and . . . → Read More: Patent Awarded for Spinal Disc Regeneration Technology Comments are closed Intellectual property biomedical, biotechnology, life sciences, medical device, patent, USPTO Ada Poon (L.A. Cicero, Stanford University) 20 May 2014. Engineers and medical researchers at Stanford University in California designed a wireless system that can transfer electric power deep inside the body for miniaturized implants and other therapies. The work of a team led by electrical engineering professor Ada Poon was published online yesterday . . . → Read More: Wireless Power System Invented for Miniaturized Implants Comments are closed New products biomedical, energy, engineering, heart disease, life sciences, medical device, physical sciences, physics, university Multiple myeloma cells (NIH.gov) 19 May 2014. Bristol-Myers Squibb in New York says its engineered antibody elotuzumab received a breakthrough therapy designation from the U.S. Food and Drug Administration to treat multiple myeloma, when used with two other cancer drugs. Elotuzumab is being developed by Bristol-Myers Squibb and AbbVie, in North Chicago, Illinois. . . . → Read More: Engineered Antibody Given FDA Breakthrough Tag for Myeloma Comments are closed Regulations biomedical, cancer, clinical trials, FDA, life sciences, pharmaceuticals (George Shuklin/Wikimedia Commons) 16 May 2014. Kymab Ltd., a developer of human antibodies from mouse genomes, raised $40 million in its second round of venture investment from the Wellcome Trust, an original backer of the company, and Bill & Melinda Gates Foundation. Kymab, based in Cambridge, U.K., is also collaborating with the Gates . . . → Read More: Antibody Developer Secures $40M from Foundation Investors Comments are closed Finance biomedical, biotechnology, entrepreneurs, equity, Europe, genomics, investment, life sciences, pharmaceuticals, U.K., university, venture capital Paras Prasad (University at Buffalo) 16 May 2014. Researchers from University at Buffalo in New York developed and tested in the lab a process harnessing lasers to activate drugs inside the body to kill cancer cells. Findings from the proof-of-concept study, led by Buffalo’s Paras Prasad with colleagues from universities in China and . . . → Read More: Laser Activation Tested as Potential Cancer Drug Delivery Comments are closed New products Asia, biomedical, cancer, chemistry, China, Korea, life sciences, medical device, patent, pharmaceuticals, physical sciences, physics, university |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts
You must be logged in to post a comment.